Max Robotics — Global Service Robot Directory + US Certification

About

Mark S. Swanson is a surgical oncologist whose research focuses on advancing minimally invasive head and neck cancer surgery, particularly transoral robotic surgery (TORS) and its integration with modern treatment paradigms. His major contributions center on optimizing surgical outcomes for HPV-related oropharyngeal cancer and early supraglottic cancer, where he has systematically compared surgical approaches against intensity-modulated radiotherapy (IMRT). His 2017 systematic review on early supraglottic cancer (13 citations) provides critical evidence for treatment selection, while his 2021 study on surgeon practice patterns in TORS for HPV-related oropharyngeal cancer (7 citations) illuminates real-world clinical decision-making. Notably, his 2023 work on opioid-sparing multimodal analgesia (6 citations) demonstrates a commitment to improving postoperative recovery, showing how enhanced pain management protocols can reduce narcotic use without compromising analgesia. This patient-centered research bridges surgical technique with quality of life, reflecting a holistic approach to cancer care. Swanson’s work is particularly valuable for surgeons and oncologists navigating the evolving landscape of head and neck cancer treatment, offering evidence-based guidance that balances oncologic efficacy with functional preservation and recovery.